Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Jan 31, 2026 | (FY)Jul 31, 2025 | (Q6)Jan 31, 2025 | (FY)Jul 31, 2024 | (Q6)Jan 31, 2024 | (FY)Jul 31, 2023 | (Q6)Jan 31, 2023 | (FY)Jul 31, 2022 | (Q6)Jan 31, 2022 | (FY)Jul 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 76.12%-781.06K | ---- | -590.82%-3.27M | ---- | 138.42%666.28K | ---- | -28.99%-1.73M | -80.91%-938.92K | -37.78%-1.34M |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | ---- | -178.87%-29.76K | ---- | 1,008.72%37.74K | ---- | -243.51%-4.15K | ---- | ---1.21K | ---- | ---- |
| Impairment and provisions: | ---- | -106.73%-135.02K | ---- | 14,840.40%2.01M | ---- | -72.35%13.43K | ---- | 841.90%48.57K | 105.09%420 | -100.70%-6.55K |
| -Impairment of trade receivables (reversal) | ---- | -96.89%4.98K | ---- | --160K | ---- | ---- | ---- | 841.90%48.57K | ---- | -114.45%-6.55K |
| -Other impairments and provisions | ---- | -107.58%-140K | ---- | 13,649.20%1.85M | ---- | --13.43K | ---- | ---- | 105.09%420 | ---- |
| Revaluation surplus: | ---- | ---1.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---1.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | 175.33%85.23K | ---- | 46.99%-113.14K | ---- | ---213.43K | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | 175.33%85.23K | ---- | 46.99%-113.14K | ---- | ---213.43K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 66.16%588.35K | ---- | -20.10%354.08K | ---- | -33.67%443.15K | ---- | 7.00%668.14K | 17.53%352.86K | -7.74%624.46K |
| Financial expense | ---- | -55.78%88K | ---- | 98.94%199K | ---- | 35.19%100.03K | ---- | -17.08%73.99K | -25.57%35.42K | 72.64%89.23K |
| Special items | ---- | ---- | ---- | --179.38K | ---- | ---- | ---- | --7.09K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -173.11%-1.66M | ---- | -160.32%-606.42K | ---- | 207.21%1.01M | ---- | -47.12%-937.69K | -208.59%-550.22K | -192.88%-637.36K |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -320.68%-2.93M | ---- | 328.63%1.33M | ---- | 119.26%309.29K | ---- | -465.01%-1.61M | -351.49%-629.72K | -78.96%439.87K |
| Accounts payable increase (decrease) | ---- | 628.19%2.76M | ---- | -198.40%-522.34K | ---- | 50.94%530.85K | ---- | 299.64%351.68K | 2,369.82%926.2K | 87.07%-176.16K |
| prepayments (increase)decrease | ---- | 242.22%357.1K | ---- | -962.48%-251.09K | ---- | -68.90%29.11K | ---- | 281.93%93.61K | -2,974.24%-965.77K | -109.07%-51.45K |
| Special items for working capital changes | ---- | -62.42%106.97K | ---- | 212.95%284.64K | ---- | 35.01%-252K | ---- | -352.47%-387.77K | -274.10%-128.65K | 33.96%153.59K |
| Cash from business operations | ---- | -689.48%-1.36M | ---- | -85.79%230.51K | ---- | 165.27%1.62M | ---- | -815.53%-2.49M | -1,071.42%-1.35M | -112.95%-271.51K |
| Other taxs | ---- | 193.35%94.53K | ---- | -713.23%-101.26K | ---- | 65.37%16.51K | ---- | 181.39%9.99K | 1,047.94%10.11K | 61.50%-12.27K |
| Special items of business | -6.07%-1.54M | ---- | -262.22%-1.45M | ---- | -189.96%-400.67K | ---- | --445.38K | ---- | ---- | ---- |
| Net cash from operations | -6.07%-1.54M | -1,078.13%-1.26M | -262.22%-1.45M | -92.11%129.25K | -189.96%-400.67K | 166.20%1.64M | 133.29%445.38K | -772.43%-2.48M | -1,071.60%-1.34M | -113.74%-283.78K |
| Cash flow from investment activities | ||||||||||
| Purchase of fixed assets | ---- | -50.65%-541.73K | ---- | -999.93%-359.6K | ---- | 10.55%-32.69K | ---- | -348.62%-36.55K | ---26.27K | 97.83%-8.15K |
| Sale of subsidiaries | ---- | -4,463.93%-139.43K | ---- | 66.34%-3.06K | ---- | ---9.08K | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --572 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---186.77K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | 480.76%1.32M | ---- | -133.56%-346K | ---- | 4,358.36%1.03M | ---- | ---24.21K | ---- | ---- | ---- |
| Net cash from investment operations | 480.76%1.32M | -139.17%-867.36K | -133.56%-346K | -768.24%-362.66K | 4,358.36%1.03M | -14.28%-41.77K | 7.82%-24.21K | -348.62%-36.55K | ---26.27K | 97.83%-8.15K |
| Net cash before financing | 87.65%-221.99K | -813.29%-2.13M | -385.10%-1.8M | -114.61%-233.4K | 49.68%630.41K | 163.58%1.6M | 130.87%421.16K | -760.61%-2.51M | -1,090.68%-1.36M | -117.27%-291.93K |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 339.67%2.75M | ---- | -12.94%625.86K | ---- | -64.37%718.91K | ---- | -37.76%2.02M | -37.12%1.08M | -39.35%3.24M |
| Refund | ---- | -220.63%-2.63M | ---- | -48.45%-819.99K | ---- | 72.94%-552.36K | ---- | 43.25%-2.04M | 27.88%-1.29M | 43.96%-3.6M |
| Issuing shares | ---- | ---- | ---- | --2.47M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance of bonds | ---- | ---- | ---- | --1.03M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 14.03%-72.68K | ---- | 12.74%-84.54K | ---- | -77.98%-96.89K | ---- | 27.66%-54.44K | 29.42%-28.38K | -149.47%-75.25K |
| Issuance expenses and redemption of securities expenses | ---- | -770.14%-1.11M | ---- | ---127.12K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 107.02%91.52K | ---- | -131,576.41%-1.3M | ---- | -98.97%992 | ---- | --95.88K | ---- | ---- | ---- |
| Net cash from financing operations | 107.02%91.52K | -149.23%-1.39M | -131,576.41%-1.3M | 975.17%2.83M | -98.97%992 | 46.85%-323.23K | 119.41%95.88K | 22.63%-608.17K | -83.90%-493.92K | -196.89%-786.04K |
| Effect of rate | -56.36%10.37K | 1,245.64%11.57K | -27.81%23.76K | -107.21%-1.01K | 158.95%32.92K | 2,263.99%14K | 1,411.41%12.71K | -170.71%-647 | 39.70%841 | 498.04%915 |
| Net Cash | 95.79%-130.47K | -235.79%-3.52M | -591.21%-3.1M | 103.71%2.6M | 22.12%631.4K | 140.83%1.27M | 127.82%517.05K | -189.48%-3.12M | -1,320.05%-1.86M | -143.10%-1.08M |
| Begining period cash | -84.57%640.9K | 166.39%4.15M | 166.39%4.15M | 475.04%1.56M | 475.04%1.56M | -92.01%271.15K | -92.01%271.15K | -24.10%3.39M | -24.10%3.39M | 127.11%4.47M |
| Cash at the end | -51.59%520.8K | -84.57%640.9K | -51.61%1.08M | 166.39%4.15M | 177.63%2.22M | 475.04%1.56M | -47.82%800.9K | -92.01%271.15K | -64.63%1.53M | -24.10%3.39M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -51.59%520.8K | ---- | --1.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Changqing (Hong Kong) Certified Public Accountants Limited | -- | Changqing (Hong Kong) Certified Public Accountants Limited | -- | Changqing (Hong Kong) Certified Public Accountants Limited | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.